Ephedra Viridis Topical Preparation for HSV Treatment
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current treatments for herpes simplex virus (HSV) infections, such as cold sores, are costly and often ineffective in reducing the duration and severity of outbreaks, with antiviral medications facing challenges like drug resistance and over-the-counter topical treatments providing limited relief.
Innovation Solution
A topical skin preparation using a plant-based composition comprising an extract from Ephedra viridis, combined with other natural ingredients like Rumex crispus and Plantago lanceolata, applied topically to alleviate symptoms and accelerate healing of HSV blisters and other skin inflammatory conditions.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If antiviral medications are used to treat HSV infections, then the viral activity is suppressed, but the manufacturing cost increases excessively and drug resistance develops
Solution Approach 1:
The patent replaces expensive pharmaceutical antiviral medications with a cost-effective plant-based extract (Ephedra viridis) that can be manufactured at lower cost. The formulation uses natural ingredients that are more economical to produce while maintaining therapeutic effectiveness, directly addressing the contradiction between treatment reliability and manufacturing cost.
Solution Approach 2:
The patent changes the chemical composition parameters by using plant-derived compounds instead of synthetic pharmaceuticals. This parameter change allows for cost reduction in manufacturing while maintaining the therapeutic effect of suppressing viral activity, resolving the contradiction between effectiveness and manufacturing cost.
2Ease of operation
If over-the-counter topical treatments are used to reduce pain and appearance of cold sores, then symptom relief is provided, but the duration of the cold sore remains unchanged and manufacturing costs are excessive
Solution Approach 1:
The patent provides a cost-effective alternative to expensive OTC topical treatments. The plant-based formulation reduces manufacturing costs while also addressing the limitation of OTC treatments that fail to reduce cold sore duration, achieving both economic and temporal benefits.
Solution Approach 2:
The patent creates a composite topical formulation combining Ephedra viridis extract with other natural ingredients (Rumex crispus, Plantago lanceolata, and carrier oils). This composite approach enhances the therapeutic effectiveness to reduce cold sore duration while maintaining cost-effectiveness, resolving the contradiction between symptom relief and treatment duration.
3Reliability
If extensive use of viral drugs is made, then HSV activity is controlled, but treatment failure increases due to drug resistance
Solution Approach 1:
The patent replaces synthetic viral drugs with a plant-based extract that does not contribute to drug resistance development. This substitution maintains the ability to control viral activity while eliminating the harmful effect of drug resistance, as the natural compounds do not exert selective pressure for resistant strains.
Solution Approach 2:
The patent converts the potential harm of viral drug resistance into a benefit by using natural plant compounds that work through different mechanisms. The Ephedra viridis extract and associated plant ingredients provide antiviral activity without the resistance problem, turning the limitation of conventional drugs into an opportunity to use alternative, resistance-free treatments.
Data Source
AI summary
A method and related topical skin preparation comprising an extract from Ephedra viridis. The disclosed method and preparation treat fever blisters caused by herpes simplex virus and other skin-related inflammatory conditions.